Indication
Chronic hepatitis C
Chronic hepatitis C is a persistent, blood-borne hepatic infection caused by the hepatitis C virus (HCV) that fails to clear spontaneously within six months. Read more about Chronic hepatitis C
6 drugs 2 manufacturers
Drugs that treat it
Common Chronic hepatitis C therapies.
INTRON A (interferon alfa-2b,recomb.)
INTRON A (interferon alfa-2b,recomb.)
INTRON A (interferon alfa-2b,recomb.)
INTRON A (interferon alfa-2b,recomb.)
INTRON A (interferon alfa-2b,recomb.)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic hepatitis C is a persistent, blood-borne hepatic infection caused by the hepatitis C virus (HCV) that fails to clear spontaneously within six months.
Primarily affecting hepatocytes and the immune system, the condition is characterized pathophysiologically by ongoing immune-mediated inflammation, progressive hepatic fibrosis, and hepatocellular injury.
Clinically, it is defined by detectable circulating HCV RNA and is frequently asymptomatic or clinically indolent for decades until advanced liver disease manifests.
Over time, persistent viremia can lead to severe complications, including cirrhosis, portal hypertension, end-stage liver failure, and hepatocellular carcinoma.
- medlineplus.gov
Chronic hepatitis C is a persistent, blood-borne hepatic infection caused by the hepatitis C virus (HCV) that fails to clear spontaneously within six months Primarily affecting hepatocytes and the immune system, the condition is characterized pathophysiologically by ongoing immune-mediated inflammation, progressive hepatic fibrosis, and hepatocellular injury
- nih.gov
Chronic hepatitis C is a persistent, blood-borne hepatic infection caused by the hepatitis C virus (HCV) that fails to clear spontaneously within six months Over time, persistent viremia can lead to severe complications, including cirrhosis, portal hypertension, end-stage liver failure, and hepatocellular carcinoma
- nih.gov
Chronic hepatitis C is a persistent, blood-borne hepatic infection caused by the hepatitis C virus (HCV) that fails to clear spontaneously within six months Clinically, it is defined by detectable circulating HCV RNA and is frequently asymptomatic or clinically indolent for decades until advanced liver disease manifests Over time, persistent viremia can lead to severe complications, including cirrhosis, portal hypertension, end-stage liver failure, and hepatocellular carcinoma
- merckmanuals.com
Primarily affecting hepatocytes and the immune system, the condition is characterized pathophysiologically by ongoing immune-mediated inflammation, progressive hepatic fibrosis, and hepatocellular injury Clinically, it is defined by detectable circulating HCV RNA and is frequently asymptomatic or clinically indolent for decades until advanced liver disease manifests
Personalize your experience
Follow Chronic hepatitis C and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.